ALDOA Expression in Bladder Urothelial Carcinoma
Launched by ASSIUT UNIVERSITY · Aug 9, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "ALDOA Expression in Bladder Urothelial Carcinoma" is looking to investigate a specific protein called ALDOA in patients with bladder cancer. Researchers want to understand how the presence of this protein relates to different characteristics of the cancer and how it may affect a patient’s prognosis or chances of survival. By studying tissue samples from patients diagnosed with bladder urothelial carcinoma, the trial aims to gather important information that could help in the future treatment and management of this type of cancer.
To be eligible for the trial, participants must have a diagnosis of bladder urothelial cancer with specific follow-up information available and certain types of muscle tissue present in their samples. Unfortunately, patients with other types of bladder cancer, without follow-up data, or lacking the necessary muscle tissue in their samples will not be included. The trial is not yet recruiting participants, but it aims to provide valuable insights that could improve outcomes for those affected by bladder cancer. If you or a loved one fit the criteria and are interested in participating when the trial begins, you may have the opportunity to contribute to important cancer research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All cases diagnosed as bladder urothelial cancer with known follow-up data and presence of muscle proper detected in the specimens.
- Exclusion Criteria:
- • 1. Subtypes of bladder cancer other than urothelial carcinoma subtype.
- • 2. Cases of urothelial carcinoma without known follow up data.
- • 3. Cases of urothelial carcinoma without muscle proper detected in the specimen.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Dalia Elsers, Professor
Study Director
Head of Pathology Department
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported